Anxiety Sensitivity Treatment for Heroin Users
Not Applicable
Completed
- Conditions
- Anxiety
- Registration Number
- NCT01196312
- Lead Sponsor
- University of Maryland, College Park
- Brief Summary
Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- exhibit a score of 21 on a self-report measure of anxiety sensitivity
- be in 28 days of residential substance use treatment.
- meet criteria for current opioid dependence as determined by SCID interview administered at intake.
Read More
Exclusion Criteria
- evidence of limited mental competency
- the inability to give informed, voluntary, written consent to participate
- current psychosis
- current bipolar disorder.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Anxiety Sensitivity Index-3 24 weeks
- Secondary Outcome Measures
Name Time Method Timeline Follow Back 90 days 24 weeks
Trial Locations
- Locations (1)
Salvation Army Harbor Light Treatment Facilitiy
🇺🇸Washington, District of Columbia, United States